Hypoglycemia-Induced Bradycardia

Clinical Evidence and Mechanism

Simultaneous glucose and ambulatory ECG monitoring has demonstrated that bradycardia, along with atrial and ventricular ectopic beats, occurs more commonly during nocturnal hypoglycemia in patients with diabetes, providing a possible mechanism for increased death rates during intensive glycemic control, including the "dead-in-bed syndrome," according to the European Society of Cardiology 1, 2
The American College of Cardiology recommends that patients with symptomatic bradycardia from hypoglycemia should have therapy directed at eliminating the offending condition (treating the hypoglycemia), not cardiac pacing, with a strength of evidence based on clinical trials 3

Patients at increased risk for hypoglycemia-induced bradycardia include those with nephropathy, autonomic neuropathy, or prolonged QTc interval, as well as patients on negative chronotropic medications (beta-blockers, calcium channel blockers, digoxin), and elderly patients with underlying heart disease, according to the European Heart Journal 1, 2
The American College of Cardiology also notes that patients on negative chronotropic medications are at increased risk for hypoglycemia-induced bradycardia 3

The American College of Cardiology recommends that after any episode of bradycardia associated with hypoglycemia, the diabetes treatment plan should be reevaluated to avoid further episodes, with a focus on adjusting medications and glycemic targets 3

The American College of Cardiology, American Heart Association, and Heart Rhythm Society guidelines document marked sinus bradycardia and QT prolongation in diabetic patients with severe hypoglycemia 4

Beta-adrenergic blockade can mask early hypoglycemic symptoms, including tachycardia, making bradycardia recognition more critical, according to the American Academy of Pediatrics 5
The American Diabetes Association recommends immediately treating hypoglycemia first, with glucose as the preferred treatment for conscious patients with glucose <70 mg/dL 6
The American College of Cardiology, American Heart Association, and Heart Rhythm Society guidelines state that patients with symptomatic bradycardia from reversible causes should have therapy directed at eliminating the offending condition, not pacing 7

The American Diabetes Association recommends reevaluating the diabetes treatment plan after any episode of bradycardia associated with hypoglycemia, including screening for impaired hypoglycemia awareness at least annually 6
The American College of Cardiology recommends reviewing and potentially reducing or discontinuing negative chronotropic medications if they contributed to the event 7

When blood glucose falls below 70 mg/dL, counter‑regulatory hormones (epinephrine, glucagon, cortisol) trigger an initial sympathetic surge that produces tachycardia, sweating, and shakiness. 8

A recent episode of severe hypoglycemia within the past 3–6 months markedly increases the likelihood of arrhythmias. 8
Impaired awareness of hypoglycemia is a significant risk factor for cardiac rhythm disturbances. 8
End‑stage kidney disease confers a high risk for hypoglycemia‑induced arrhythmias. 8
Cognitive impairment or dementia elevates the risk of hypoglycemia‑related cardiac events. 8
Intensive insulin therapy predisposes patients to hypoglycemia‑associated arrhythmias. 8

For conscious patients with glucose < 70 mg/dL, immediate administration of oral or intravenous glucose is the preferred treatment; cardiac pacing is not indicated. 8
Impaired hypoglycemia awareness should be screened for at every clinical encounter. 8
Continuous glucose monitoring should be considered for patients identified as high‑risk. 8

Diabetic cardiac autonomic neuropathy causes permanent resting tachycardia and orthostatic hypotension due to parasympathetic denervation. 9
CAN is present in approximately 20 % of diabetic individuals when defined by two or three abnormal heart‑rate variability tests. 9
The prevalence of CAN rises with longer diabetes duration and poorer glycemic control. 9
CAN substantially increases the risk of sudden death secondary to serious cardiac rhythm disorders. 9

Chronic hyperglycemia contributes to the development of CAN, leading to baseline tachycardia. [9][10]
Persistent hyperglycemia is associated with QTc interval prolongation, heightening arrhythmic risk. 10
Diabetic patients have a 2–3‑fold higher risk of developing heart failure as a long‑term cardiovascular complication of hyperglycemia. 9